RU2000119761A - THERAPEUTIC TOOLS - Google Patents
THERAPEUTIC TOOLSInfo
- Publication number
- RU2000119761A RU2000119761A RU2000119761/14A RU2000119761A RU2000119761A RU 2000119761 A RU2000119761 A RU 2000119761A RU 2000119761/14 A RU2000119761/14 A RU 2000119761/14A RU 2000119761 A RU2000119761 A RU 2000119761A RU 2000119761 A RU2000119761 A RU 2000119761A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- enantiomers
- methyl
- Prior art date
Links
- 230000001225 therapeutic Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 16
- 150000003839 salts Chemical class 0.000 claims 7
- 239000011780 sodium chloride Substances 0.000 claims 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 208000008589 Obesity Diseases 0.000 claims 5
- 235000020824 obesity Nutrition 0.000 claims 5
- AHLBNYSZXLDEJQ-FWEHEUNISA-N Orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 claims 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N Sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229960001243 orlistat Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 0 *C1(CCC1)c1ccc(*)cc1 Chemical compound *C1(CCC1)c1ccc(*)cc1 0.000 description 1
Claims (8)
включая его энантиомеры и фармацевтически приемлемые соли,
где R1 и R2 независимо означают водород или метил,
и терапевтически эффективного количества соединения формулы II
в котором соединение формулы I и соединение формулы II назначают одновременно, раздельно или последовательно.1. A method of treating obesity in a person in need of such treatment, including administering to such a person a therapeutically effective amount of a compound of formula I
including its enantiomers and pharmaceutically acceptable salts,
where R 1 and R 2 independently mean hydrogen or methyl,
and a therapeutically effective amount of a compound of formula II
wherein the compound of formula I and the compound of formula II are administered simultaneously, separately or sequentially.
включая его энантиомеры и фармацевтически приемлемые соли,
где R1 и R2 независимо означают водород или метил,
и соединение формулы II
вместе с фармацевтически приемлемым разбавителем или носителем.8. Pharmaceutical composition comprising a compound of formula I
including its enantiomers and pharmaceutically acceptable salts,
where R 1 and R 2 independently mean hydrogen or methyl,
and the compound of formula II
together with a pharmaceutically acceptable diluent or carrier.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE9727131.6 | 1997-12-24 | ||
DE9727131 | 1997-12-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2000119761A true RU2000119761A (en) | 2002-08-10 |
RU2234917C2 RU2234917C2 (en) | 2004-08-27 |
Family
ID=33316965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2000119761/15A RU2234917C2 (en) | 1997-12-24 | 1998-12-16 | Therapeutic agents |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2234917C2 (en) |
-
1998
- 1998-12-16 RU RU2000119761/15A patent/RU2234917C2/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95107881A (en) | Pharmaceutical composition for allergic disease treatment, method of antihistamine treatment, use of composition for medicinal preparation preparing | |
RU2330661C2 (en) | Combinations containing antidiarrheal agent and epothylon or epothylon derivatives | |
EP2036902A3 (en) | Urea compounds active as vanilloid receptor antagonist for the treatment of pain | |
RU2004110055A (en) | NEW DIPEPTIDYL PEPTIDASE IV INHIBITORS AS ANTI-DIABETIC AGENTS | |
RU2000106597A (en) | NEW APPLICATION OF BUDESONIDE AND FORMOTHEROL | |
CA2302700A1 (en) | New use for budesonide and formoterol | |
LU90956I2 (en) | Metvix active ingredient methylaminolevulinic in the form of a salt preferably methylaminolevulinic hydrochloride | |
RU94013439A (en) | HETEROCYCLIC COMPOUNDS, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT | |
CA2284732A1 (en) | Analogs of ***e | |
AU2002251067A1 (en) | Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative | |
RU2004136853A (en) | (S) -4-amino-5-chloro-2-methoxy-n- [1- [1- (2-tetrahydrofurylcarbonyl) -4-piperidini-methyl] -4-piperidinyl] benzamide, method of obtaining it, commercially AND INTERMEDIATE CONNECTION FOR ITS PRODUCTION | |
JP2006514092A5 (en) | ||
RU95101385A (en) | Products containing g-csf and tnf-binding protein | |
WO1999033450A3 (en) | Pharmaceutical composition containing sibutramine and orlistat | |
RU2008108175A (en) | COMBINATION OF COMPOUNDS THAT CAN BE USED IN THE TREATMENT OF RESPIRATORY DISEASES, ESPECIALLY CHRONIC EXTRACTIVE LUNG DISEASE (COPO) AND ASTHMA | |
RU2003130644A (en) | RARCARBOLINE DERIVATIVES AND THEIR PHARMACEUTICAL USE AGAINST DIPRESSION AND FEAR | |
ZA922910B (en) | Heterocylic pharmaceutical compounds preparation and use | |
RU2000106042A (en) | METHOD FOR INCREASING THE BIOLOGICAL ACCESSIBILITY OF FEXOPHENADINE AND ITS DERIVATIVES | |
RU2004131214A (en) | METHODS FOR TREATING COGNITIVE DISORDERS | |
IL43820A (en) | Pharmaceutical compositions for treatment of spastically disabled human beings containing bronchodilating sympathomimetic amines | |
CA2450915A1 (en) | Use of levosimendan and beta-adrenergic receptor antagonist for the treatment of heart failure | |
JPH06321774A (en) | Anesthetic composition containing general anesthetic and selegiline | |
RU2000119761A (en) | THERAPEUTIC TOOLS | |
CA2368352A1 (en) | Method for treating neurodegeneration | |
MY133438A (en) | Morpholinobenzamide salts |